HomeHUMA • NASDAQ
Humacyte Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 517.00K | — |
Operating expense | 8.14M | 53.11% |
Net income | 39.14M | 222.71% |
Net profit margin | 7.57K | — |
Earnings per share | -0.08 | 68.12% |
EBITDA | -21.35M | 13.86% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 62.85M | -45.59% |
Total assets | 162.55M | 0.67% |
Total liabilities | 126.51M | -6.51% |
Total equity | 36.04M | — |
Shares outstanding | 155.12M | — |
Price to book | 10.83 | — |
Return on assets | -38.59% | — |
Return on capital | -78.72% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 39.14M | 222.71% |
Cash from operations | -28.60M | -4.59% |
Cash from investing | -228.00K | 41.69% |
Cash from financing | 46.74M | -25.57% |
Net change in cash | 17.91M | -48.91% |
Free cash flow | -20.91M | -10.06% |
Previous close
$2.49
Day range
$2.36 - $2.54
Year range
$1.15 - $9.97
Market cap
381.73M USD
Avg Volume
4.22M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
Jan 1, 2004
Website
Employees
219